Pain Management is a medical approach that draws on disciplines in science and alternative healing to study the prevention, diagnosis, and treatment of pain. Veterinary pain management is an important part of veterinary therapeutics. Pain management practice provides veterinary practitioners with the information needed to both recognize and manage pain in a wide range of animals. FDA (the Food and Drug Administration) has approved several non-steroidal anti-inflammatory drugs (NSAIDs) for dogs to control pain and inflammation associated with OA (osteoarthritis). NSAIDs are one of the most commonly used and most effective drug in the treatment of pain due to arthritis or after surgery.

Market Dynamics

Increasing prevalence of animal disease, need for pain management, and increase in safe and effective pain management, and favorable government initiatives are major factors expected to aid in the growth of the global veterinary pain management market during the forecast period. Laser treatments are an excellent way to provide pain relief to a companion. The therapy helps promote healing of tissue and relieve pain through a process called photobiomodulation. Lasers can modulate the inflammatory process, reduce pain, and accelerate tissue healing.

In October 2020, Summus Laser, the leading provider of high-powered laser therapy products, announced the launch of the Horizon Veterinary Laser System, the first Class IV therapy laser system designed specifically for the veterinary pain management.

Key features of the study

• The report provides in-depth analysis of the global veterinary pain management market, and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global veterinary pain management market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Zoetis Inc., Vetoquinol SA, Norbrook, Dechra Pharmaceuticals PLC, Chanelle Veterinary Limited, Ceva Sante Animale, Assisi Animal Health, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global veterinary pain management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary pain management market.

Market Segmentation

• By Product
  • Drugs
  • Devices
• By Application
  • Osteoarthritis and Joint Pain
  • Postoperative Pain
  • Cancer
  • Others
• By Animal type
  • Companion
  • Livestock
• By End User
  • Hospitals and Clinics
  • Retail Outlet & Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Key Players
  • Zoetis Inc.
  • Vetoquinol SA
  • Norbrook
  • Dechra Pharmaceuticals PLC
  • Chanelle Veterinary Limited
  • Ceva Sante Animale
  • Assisi Animal Health
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH